 | • レポートコード：GIR201113088 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、白血球表面抗原CD47の世界市場を調査対象にし、白血球表面抗原CD47の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（B-6H12、ALX-148、CC-90002、PSTx-23、その他）、用途別分析（リンパ腫、卵巣癌、虚血再灌流障害、腎臓移植拒絶反応、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Aurigene Discovery Technologies Ltd、Surface Oncology Inc、Celgene Corp、Forty Seven Inc、Trillium Therapeutics Inc ・メーカー別販売量、売上、市場シェア ・白血球表面抗原CD47の地域別市場分析 ・白血球表面抗原CD47の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・白血球表面抗原CD47のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・白血球表面抗原CD47のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・白血球表面抗原CD47の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・白血球表面抗原CD47の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・白血球表面抗原CD47の種類別市場規模2015-2020：B-6H12、ALX-148、CC-90002、PSTx-23、その他 ・白血球表面抗原CD47の用途別市場規模2015-2020：リンパ腫、卵巣癌、虚血再灌流障害、腎臓移植拒絶反応、その他 ・白血球表面抗原CD47の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Leukocyte Surface Antigen CD47 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Leukocyte Surface Antigen CD47 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Leukocyte Surface Antigen CD47 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Leukocyte Surface Antigen CD47 market has been segmented into
B-6H12
ALX-148
CC-90002
PSTx-23
Others
By Application, Leukocyte Surface Antigen CD47 has been segmented into:
Lymphoma
Ovarian Cancer
Ischemia Reperfusion Injury
Kindney Transplant Rejection
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Leukocyte Surface Antigen CD47 market presented in the report. This section sheds light on the sales growth of different regional and country-level Leukocyte Surface Antigen CD47 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Leukocyte Surface Antigen CD47 market.
The report offers in-depth assessment of the growth and other aspects of the Leukocyte Surface Antigen CD47 market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Leukocyte Surface Antigen CD47 Market Share Analysis
Leukocyte Surface Antigen CD47 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Leukocyte Surface Antigen CD47 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Leukocyte Surface Antigen CD47 sales, revenue and market share for each player covered in this report.
The major players covered in Leukocyte Surface Antigen CD47 are:
Aurigene Discovery Technologies Ltd
Surface Oncology Inc
Celgene Corp
Forty Seven Inc
Trillium Therapeutics Inc
Among other players domestic and global, Leukocyte Surface Antigen CD47 market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Leukocyte Surface Antigen CD47 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Leukocyte Surface Antigen CD47, with price, sales, revenue and global market share of Leukocyte Surface Antigen CD47 in 2018 and 2019.
Chapter 3, the Leukocyte Surface Antigen CD47 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Leukocyte Surface Antigen CD47 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Leukocyte Surface Antigen CD47 market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Leukocyte Surface Antigen CD47 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Leukocyte Surface Antigen CD47 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Leukocyte Surface Antigen CD47 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 B-6H12
1.2.3 ALX-148
1.2.4 CC-90002
1.2.5 PSTx-23
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Leukocyte Surface Antigen CD47 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Lymphoma
1.3.3 Ovarian Cancer
1.3.4 Ischemia Reperfusion Injury
1.3.5 Kindney Transplant Rejection
1.3.6 Others
1.4 Overview of Global Leukocyte Surface Antigen CD47 Market
1.4.1 Global Leukocyte Surface Antigen CD47 Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Aurigene Discovery Technologies Ltd
2.1.1 Aurigene Discovery Technologies Ltd Details
2.1.2 Aurigene Discovery Technologies Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Aurigene Discovery Technologies Ltd SWOT Analysis
2.1.4 Aurigene Discovery Technologies Ltd Product and Services
2.1.5 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Surface Oncology Inc
2.2.1 Surface Oncology Inc Details
2.2.2 Surface Oncology Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Surface Oncology Inc SWOT Analysis
2.2.4 Surface Oncology Inc Product and Services
2.2.5 Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Celgene Corp
2.3.1 Celgene Corp Details
2.3.2 Celgene Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Celgene Corp SWOT Analysis
2.3.4 Celgene Corp Product and Services
2.3.5 Celgene Corp Leukocyte Surface Antigen CD47 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Forty Seven Inc
2.4.1 Forty Seven Inc Details
2.4.2 Forty Seven Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Forty Seven Inc SWOT Analysis
2.4.4 Forty Seven Inc Product and Services
2.4.5 Forty Seven Inc Leukocyte Surface Antigen CD47 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Trillium Therapeutics Inc
2.5.1 Trillium Therapeutics Inc Details
2.5.2 Trillium Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Trillium Therapeutics Inc SWOT Analysis
2.5.4 Trillium Therapeutics Inc Product and Services
2.5.5 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Leukocyte Surface Antigen CD47 Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Leukocyte Surface Antigen CD47 Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Leukocyte Surface Antigen CD47 Manufacturer Market Share in 2019
3.3.2 Top 6 Leukocyte Surface Antigen CD47 Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Leukocyte Surface Antigen CD47 Sales, Revenue and Market Share by Regions
4.1.1 Global Leukocyte Surface Antigen CD47 Sales and Market Share by Regions (2015-2020)
4.1.2 Global Leukocyte Surface Antigen CD47 Revenue and Market Share by Regions (2015-2020)
4.2 North America Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
4.3 Europe Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
4.5 South America Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Leukocyte Surface Antigen CD47 Sales, Revenue and Market Share by Country
5.1.1 North America Leukocyte Surface Antigen CD47 Sales and Market Share by Country (2015-2020)
5.1.2 North America Leukocyte Surface Antigen CD47 Revenue and Market Share by Country (2015-2020)
5.2 United States Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
5.3 Canada Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
5.4 Mexico Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Leukocyte Surface Antigen CD47 Sales, Revenue and Market Share by Country
6.1.1 Europe Leukocyte Surface Antigen CD47 Sales and Market Share by Country (2015-2020)
6.1.2 Europe Leukocyte Surface Antigen CD47 Revenue and Market Share by Country (2015-2020)
6.2 Germany Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
6.3 UK Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
6.4 France Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
6.5 Russia Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
6.6 Italy Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Leukocyte Surface Antigen CD47 Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Leukocyte Surface Antigen CD47 Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Leukocyte Surface Antigen CD47 Revenue and Market Share by Regions (2015-2020)
7.2 China Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
7.3 Japan Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
7.4 Korea Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
7.5 India Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
7.7 Australia Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Leukocyte Surface Antigen CD47 Sales, Revenue and Market Share by Country
8.1.1 South America Leukocyte Surface Antigen CD47 Sales and Market Share by Country (2015-2020)
8.1.2 South America Leukocyte Surface Antigen CD47 Revenue and Market Share by Country (2015-2020)
8.2 Brazil Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
8.3 Argentina Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Leukocyte Surface Antigen CD47 Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Leukocyte Surface Antigen CD47 Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Leukocyte Surface Antigen CD47 Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
9.3 Turkey Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
9.4 Egypt Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
9.5 South Africa Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Leukocyte Surface Antigen CD47 Sales and Market Share by Type (2015-2020)
10.2 Global Leukocyte Surface Antigen CD47 Revenue and Market Share by Type (2015-2020)
10.3 Global Leukocyte Surface Antigen CD47 Price by Type (2015-2020)
11 Global Leukocyte Surface Antigen CD47 Market Segment by Application
11.1 Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2015-2020)
11.2 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2015-2020)
11.3 Global Leukocyte Surface Antigen CD47 Price by Application (2015-2020)
12 Market Forecast
12.1 Global Leukocyte Surface Antigen CD47 Sales, Revenue and Growth Rate (2021-2025)
12.2 Leukocyte Surface Antigen CD47 Market Forecast by Regions (2021-2025)
12.2.1 North America Leukocyte Surface Antigen CD47 Market Forecast (2021-2025)
12.2.2 Europe Leukocyte Surface Antigen CD47 Market Forecast (2021-2025)
12.2.3 Asia-Pacific Leukocyte Surface Antigen CD47 Market Forecast (2021-2025)
12.2.4 South America Leukocyte Surface Antigen CD47 Market Forecast (2021-2025)
12.2.5 Middle East & Africa Leukocyte Surface Antigen CD47 Market Forecast (2021-2025)
12.3 Leukocyte Surface Antigen CD47 Market Forecast by Type (2021-2025)
12.3.1 Global Leukocyte Surface Antigen CD47 Sales Forecast by Type (2021-2025)
12.3.2 Global Leukocyte Surface Antigen CD47 Market Share Forecast by Type (2021-2025)
12.4 Leukocyte Surface Antigen CD47 Market Forecast by Application (2021-2025)
12.4.1 Global Leukocyte Surface Antigen CD47 Sales Forecast by Application (2021-2025)
12.4.2 Global Leukocyte Surface Antigen CD47 Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Leukocyte Surface Antigen CD47 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Leukocyte Surface Antigen CD47 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Leukocyte Surface Antigen CD47 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Aurigene Discovery Technologies Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Major Business
Table 9. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Total Revenue (USD Million) (2018-2019)
Table 10. Aurigene Discovery Technologies Ltd SWOT Analysis
Table 11. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product and Services
Table 12. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Surface Oncology Inc Basic Information, Manufacturing Base and Competitors
Table 14. Surface Oncology Inc Leukocyte Surface Antigen CD47 Major Business
Table 15. Surface Oncology Inc Leukocyte Surface Antigen CD47 Total Revenue (USD Million) (2018-2019)
Table 16. Surface Oncology Inc SWOT Analysis
Table 17. Surface Oncology Inc Leukocyte Surface Antigen CD47 Product and Services
Table 18. Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Celgene Corp Basic Information, Manufacturing Base and Competitors
Table 20. Celgene Corp Leukocyte Surface Antigen CD47 Major Business
Table 21. Celgene Corp Leukocyte Surface Antigen CD47 Total Revenue (USD Million) (2018-2019)
Table 22. Celgene Corp SWOT Analysis
Table 23. Celgene Corp Leukocyte Surface Antigen CD47 Product and Services
Table 24. Celgene Corp Leukocyte Surface Antigen CD47 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Forty Seven Inc Basic Information, Manufacturing Base and Competitors
Table 26. Forty Seven Inc Leukocyte Surface Antigen CD47 Major Business
Table 27. Forty Seven Inc Leukocyte Surface Antigen CD47 Total Revenue (USD Million) (2018-2019)
Table 28. Forty Seven Inc SWOT Analysis
Table 29. Forty Seven Inc Leukocyte Surface Antigen CD47 Product and Services
Table 30. Forty Seven Inc Leukocyte Surface Antigen CD47 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Trillium Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 32. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Major Business
Table 33. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Total Revenue (USD Million) (2018-2019)
Table 34. Trillium Therapeutics Inc SWOT Analysis
Table 35. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product and Services
Table 36. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Leukocyte Surface Antigen CD47 Sales by Manufacturer (2018-2019) (K Pcs)
Table 38. Global Leukocyte Surface Antigen CD47 Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Leukocyte Surface Antigen CD47 Sales by Regions (2015-2020) (K Pcs)
Table 40. Global Leukocyte Surface Antigen CD47 Sales Market Share by Regions (2015-2020)
Table 41. Global Leukocyte Surface Antigen CD47 Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Leukocyte Surface Antigen CD47 Sales by Countries (2015-2020) (K Pcs)
Table 43. North America Leukocyte Surface Antigen CD47 Sales Market Share by Countries (2015-2020)
Table 44. North America Leukocyte Surface Antigen CD47 Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Leukocyte Surface Antigen CD47 Revenue Market Share by Countries (2015-2020)
Table 46. Europe Leukocyte Surface Antigen CD47 Sales by Countries (2015-2020) (K Pcs)
Table 47. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Countries (2015-2020)
Table 48. Europe Leukocyte Surface Antigen CD47 Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Leukocyte Surface Antigen CD47 Sales by Regions (2015-2020) (K Pcs)
Table 50. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Leukocyte Surface Antigen CD47 Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Leukocyte Surface Antigen CD47 Sales by Countries (2015-2020) (K Pcs)
Table 53. South America Leukocyte Surface Antigen CD47 Sales Market Share by Countries (2015-2020)
Table 54. South America Leukocyte Surface Antigen CD47 Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Leukocyte Surface Antigen CD47 Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Leukocyte Surface Antigen CD47 Sales by Countries (2015-2020) (K Pcs)
Table 57. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue Market Share by Countries (2015-2020)
Table 60. Global Leukocyte Surface Antigen CD47 Sales by Type (2015-2020) (K Pcs)
Table 61. Global Leukocyte Surface Antigen CD47 Sales Share by Type (2015-2020)
Table 62. Global Leukocyte Surface Antigen CD47 Revenue by Type (2015-2020) (USD Million)
Table 63. Global Leukocyte Surface Antigen CD47 Revenue Share by Type (2015-2020)
Table 64. Global Leukocyte Surface Antigen CD47 Sales by Application (2015-2020) (K Pcs)
Table 65. Global Leukocyte Surface Antigen CD47 Sales Share by Application (2015-2020)
Table 66. Global Leukocyte Surface Antigen CD47 Sales Forecast by Regions (2021-2025) (K Pcs)
Table 67. Global Leukocyte Surface Antigen CD47 Market Share Forecast by Regions (2021-2025)
Table 68. Global Leukocyte Surface Antigen CD47 Sales Forecast by Type (2021-2025) (K Pcs)
Table 69. Global Leukocyte Surface Antigen CD47 Market Share Forecast by Type (2021-2025)
Table 70. Global Leukocyte Surface Antigen CD47 Sales Forecast by Application (2021-2025)
Table 71. Global Leukocyte Surface Antigen CD47 Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Leukocyte Surface Antigen CD47 Picture
Figure 2. Global Sales Market Share of Leukocyte Surface Antigen CD47 by Type in 2019
Figure 3. B-6H12 Picture
Figure 4. ALX-148 Picture
Figure 5. CC-90002 Picture
Figure 6. PSTx-23 Picture
Figure 7. Others Picture
Figure 8. Leukocyte Surface Antigen CD47 Sales Market Share by Application in 2018
Figure 9. Lymphoma Picture
Figure 10. Ovarian Cancer Picture
Figure 11. Ischemia Reperfusion Injury Picture
Figure 12. Kindney Transplant Rejection Picture
Figure 13. Others Picture
Figure 14. Global Leukocyte Surface Antigen CD47 Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Leukocyte Surface Antigen CD47 Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Leukocyte Surface Antigen CD47 Sales Market Share by Manufacturer in 2019
Figure 35. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Leukocyte Surface Antigen CD47 Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Leukocyte Surface Antigen CD47 Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global Leukocyte Surface Antigen CD47 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Regions (2015-2020)
Figure 42. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Regions in 2018
Figure 43. North America Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
Figure 44. Europe Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
Figure 46. South America Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020)
Figure 48. North America Leukocyte Surface Antigen CD47 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Leukocyte Surface Antigen CD47 Sales Market Share by Countries (2015-2020)
Figure 50. North America Leukocyte Surface Antigen CD47 Sales Market Share by Countries in 2018
Figure 51. North America Leukocyte Surface Antigen CD47 Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Leukocyte Surface Antigen CD47 Revenue Market Share by Countries in 2018
Figure 53. United States Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe Leukocyte Surface Antigen CD47 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Leukocyte Surface Antigen CD47 Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Leukocyte Surface Antigen CD47 Revenue Market Share by Countries in 2019
Figure 59. Germany Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific Leukocyte Surface Antigen CD47 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Leukocyte Surface Antigen CD47 Revenue Market Share by Regions 2019
Figure 67. China Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America Leukocyte Surface Antigen CD47 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Leukocyte Surface Antigen CD47 Sales Market Share by Countries in 2019
Figure 74. South America Leukocyte Surface Antigen CD47 Revenue Market Share by Countries in 2019
Figure 75. Brazil Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa Leukocyte Surface Antigen CD47 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global Leukocyte Surface Antigen CD47 Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Leukocyte Surface Antigen CD47 Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales Leukocyte Surface Antigen CD47 Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales Leukocyte Surface Antigen CD47 Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales Leukocyte Surface Antigen CD47 Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales Leukocyte Surface Antigen CD47 Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
ヒト白血球抗原検査の世界市場 2020年 Market Overview The Human Leukocyte Antigen Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…- 前立腺特異抗原（PSA）の世界市場 2020年 Market Overview The global Prostate Specific Antigen market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prostate Specific A…
- Tリンパ球活性化抗原CD86の世界市場 2020年 Market Overview The global T Lymphocyte Activation Antigen CD86 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The T Lympho…
- T細胞抗原Gp39の世界市場 2020年 Market Overview The global T Cell Antigen Gp39 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The T Cell Antigen Gp39 marke…
- 癌胎児性抗原関連細胞接着分子5の世界市場 2020年 Market Overview The global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million …